Cabinet approved India & Indonesia MoU cooperation in the pharmaceutical sector

Union Cabinet approved MoU between India & Indonesia on cooperation in the pharmaceutical sector: Detail, Aim, Purpose

Union Cabinet chaired by the Prime Minister Narendra Modi has approved the Memorandum of Understanding (MoU) signed between the Central Drugs Standard Control Organization (CDSCO), India and National Agency for Drug and Food Control (BPOM), Indonesia on cooperation in the field of pharmaceutical products, pharmaceutical substances, biological product and cosmetics regulatory functions.

This MoU between India & Indonesia was signed on 29th May 2018, during the visit of PM Narendra Modi to Jakarta.

The MoU will formulate a framework for lucrative cooperation and exchange of information between the two countries in matters relating to Pharmaceutical products regulation on the basis for equality, reciprocity and mutual benefit.

The MoU will also facilitate better understanding between the regulatory authorities of India-Indonesia and facilitate India's export of pharmaceutical products.

The CDSCO is a Subordinate Office of the Directorate General of Health Services, which is an attached office of the Department of Health and Family Welfare and is the National Regulatory Authority for drugs, medical devices and cosmetics in India. The BPOM regulates these products in Indonesia.

Indonesia

Capital: Jakarta (Also Largest City)

Official Language: Indonesian

Currency: Indonesian Rupiah

President: Joko Widodo